Advisory

FDA's Arthritis Advisory Committee Recommends Approval of Celltrion's CT-P13 …
Celltrion is seeking approval of CT-P13 for the treatment of a variety of serious autoimmune diseases, including Crohn's disease, ulcerative colitis and rheumatoid arthritis, among others. The Committee based its recommendation on the totality of ... [...]
1
Like
Save
FDA Advisory Panel Favors Celltrion's Biosimilar of J&J Drug
Feb. 9 — The FDA's Arthritis Advisory Committee Feb. 9 voted 21-3 in favor of a biosimilar of Johnson & Johnson's rheumatoid arthritis treatment Remicade, which, if the FDA approves it, would be the second biosimilar approved in the U.S. and the ... [...]
4
Like
Save